Turn Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TTRX and other ETFs, options, and stocks.About TTRX
Turn Therapeutics, Inc. is a pharmaceutical and medical device development company. Its primary development programs focus on dermatological diseases.
CEOBradley Burnam
CEOBradley Burnam
Employees—
Employees—
HeadquartersWestlake Village, California
HeadquartersWestlake Village, California
Founded2015
Founded2015
Employees—
Employees—
TTRX Key Statistics
Market cap92.46M
Market cap92.46M
Price-Earnings ratio-23.56
Price-Earnings ratio-23.56
Dividend yield—
Dividend yield—
Average volume72.71K
Average volume72.71K
High today—
High today—
Low today—
Low today—
Open price$3.10
Open price$3.10
Volume0.00
Volume0.00
52 Week high$26.50
52 Week high$26.50
52 Week low$2.57
52 Week low$2.57
Stock Snapshot
Turn Therapeutics(TTRX) stock is priced at $3.15, giving the company a market capitalization of 92.46M. It carries a P/E multiple of -23.56.
On 2025-12-17, Turn Therapeutics(TTRX) shares started trading at $3.10, with intraday highs of — and lows of —.
Trading volume for Turn Therapeutics(TTRX) stock has reached 0, versus its average volume of 72.71K.
The stock's 52-week range extends from a low of $2.57 to a high of $26.50.
The stock's 52-week range extends from a low of $2.57 to a high of $26.50.
People also own
Based on the portfolios of people who own TTRX. This list is generated using Robinhood data, and it’s not a recommendation.